Kainova Therapeutics Announces Positive Phase I Results for DT-9081, an Oral EP4 Receptor Antagonist, in Advanced Solid Tumors
Article Date
March 10, 2026
This article is featured on another website.
Go to article
January 30, 2026
HiRO and Hallym University Sacred Heart Hospital Sign Strategic MOU to Advance Drug Development
Harvest Integrated Research Organization (HiRO), a boutique global CRO, is pleased to announce the signing…
January 30, 2026
HiRO and Hallym University Sacred Heart Hospital Sign Strategic MOU to Advance Drug Development
Harvest Integrated Research Organization (HiRO), a boutique global CRO, is pleased to announce the signing…
January 28, 2026
Why Australia & New Zealand Are Smart Alternatives for Your Clinical Trial During FDA Uncertainty
Navigating the Next Few Years with Confidence 2025 has been marked by significant regulatory…
January 28, 2026
Why Australia & New Zealand Are Smart Alternatives for Your Clinical Trial During FDA Uncertainty
Navigating the Next Few Years with Confidence 2025 has been marked by significant regulatory…